---
title: uBriGene vs Viralgen
slug_a: ubrigene
slug_b: viralgen
site: cdmo
review_signal_gate: closed
canonical_path: /compare/ubrigene/viralgen
generated_by: BioBM Editorial AI
---

# uBriGene vs Viralgen

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

uBriGene (ubrigene) is listed for both. uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing.

Services: 5. Modalities: 4. Indications: 1. Locations: 3. Certifications: 3. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (5).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Viralgen (viralgen) is listed for cdmo. Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.

Services: 4. Modalities: 2. Indications: 1. Locations: 1. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (4).

Review summary: Review summary withheld until site-level review gate opens.